Skip to content
Investors

"One of the Core Values we live by at Danaher is We Compete for Shareholders, and we believe we are uniquely positioned to deliver meaningful, long-term shareholder value for many years to come."

RAINER M. BLAIR
President and CEO

NYSEDHR

Investor Relations

Danaher’s proven business system drives performance. We are proud to be a Fortune 200 company, and our stock has outperformed the S&P 500 index by more than 2,000% over the past 25 years.

Press Releases
Feb 21, 2024

Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.27 per share of its common stock, payable on April 26, 2024 to...

Feb 5, 2024

Danaher Beacon for Preclinical Drug Safety seeks to address major cause of failure in clinical trials Program will leverage automated liver organoid technology for drug toxicity screening Aims to...

Jan 30, 2024

Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the fourth quarter and full year 2023. All results in this release reflect only continuing operations unless otherwise...

View all news

Company Overview

Danaher Overview Presentation

Download presentation

Sustainability

2023 Sustainability Report

Download report

Danaher Business System

The Danaher Business System (DBS) is our system of continuous improvement and the culture that makes it work.

See the DBS difference

Contact Investor Relations

John Bedford
Vice President
Investor Relations

Travis Taylor
Manager
Investor Relations

IR Team Contact Info
Email: investor.relations@danaher.com
Tel: +1 202 828 0850

Contact us

Subscribe to Investor Updates

Sign up to receive updates on the latest investor events, reports, news and more from our IR team.

Subscribe